Trump Bought Axon Stock Before ICE Taser Deal

President Donald Trump made significant stock purchases in Axon Enterprise, the manufacturer of Tasers, body cameras, and policing software, approximately two weeks before Immigration and Customs Enforcement (ICE) initiated a substantial contract solicitation that experts suggest was tailored to Axon’s product offerings.

On February 10th, Trump acquired between $1 million and $5 million worth of Axon stock, according to federal disclosures filed in May. This was followed by an ICE notice on February 24th, seeking to procure approximately 17,800 new Tasers, along with an unspecified quantity of cartridges and training services.

The White House has asserted that President Trump’s assets are managed by independent third-party firms through a trust overseen by his children, and that he has no direct involvement in investment decisions. A spokesperson for the White House stated that there are no conflicts of interest, characterizing such scrutiny as a “tired narrative.”

Trump’s disclosures to the U.S. Office of Government Ethics, released on May 14th, revealed over 3,700 transactions, with investment values presented in ranges rather than exact figures. Federal law provides presidents with an exemption from the criminal conflict-of-interest statute applicable to most executive branch officials.

While the ICE notice does not explicitly name Axon, which holds an estimated 90% market share for Tasers in the U.S., the detailed specifications for “conductive-energy weapons” strongly indicate Axon as the intended supplier. Procurement reviewers and policing experts have indicated that the requirements align almost exclusively with Axon’s existing product lines. Axon is already a supplier of Tasers to the federal government.

If finalized, this potential contract would more than quadruple ICE’s current Taser inventory, replacing approximately 4,300 devices currently in operation, according to the February notice. The notice specifically references an upgrade to Axon’s “TASER 10” model, designated as “T10,” to supersede ICE’s older “X26P/X2 Tasers,” which are also manufactured by Axon. Key features mentioned, such as a 45-foot range and the capacity for 10 individually targeted probes, are characteristic of the TASER 10, effectively limiting competition from other manufacturers, according to procurement experts.

There is no evidence to suggest President Trump’s direct involvement in the procurement process, nor that contracting officials were aware of his stock purchase, or that Axon was privy to Trump being a shareholder. The stock purchase occurred before it became publicly known through his financial disclosure. The records do not indicate that Axon had access to non-public information regarding the president’s personal investments. The ICE notice was part of the standard federal procurement process, and no contract award has been recorded to date. As it was a “Request For Information,” there is no public record of any vendor responses.

Axon has not provided comment on potential discussions with ICE, DHS, or White House officials prior to the February 24th notice. However, the timing of the notice, in close proximity to Trump’s stock acquisition, has raised ethical questions for experts in the field.

This procurement also occurs against the backdrop of the administration’s broader immigration enforcement initiatives, including its commitment to mass deportations. The purchase was made weeks after federal agents in Minneapolis were involved in a shooting incident involving individuals protesting immigration enforcement actions in the city. Such incidents have drawn criticism from civil rights advocates regarding the extent of law enforcement actions.

“What happened [in Minneapolis] showed how ICE agents have a hard job,” stated Deborah Fleischaker, former acting chief of staff at ICE during the Biden administration. “The agency has a responsibility to ensure they have appropriate modern tools and training, but it’s vital that new purchases are made for the right reasons.” Fleischaker, now a senior advisor for immigration policy and strategy at UnidosUS, commented that the timing “raises red flags,” while emphasizing the difficulty of definitively assessing any impropriety from public records alone.

“It is not prudent to invest in a company whose business could be directly influenced by the decisions made at the agency,” Fleischaker added. “One should aim to avoid not only actual impropriety but also the mere appearance of it.”

Ethics experts highlight that the primary concern lies not with proven wrongdoing, but with the perception of a conflict of interest.

“The concern is that [Trump] invested in a company whose business could grow if his administration were to expand immigration enforcement,” said Jordan Libowitz, vice president of communications at Citizens for Responsibility and Ethics in Washington. CREW, a nonpartisan watchdog group, monitors government ethics.

Axon’s stock experienced a notable increase, rising over 22% in the month following Trump’s purchase, before moderating. As of the close on June 26th, the stock showed an approximate 7% gain since his purchase date. If Trump invested at the higher end of the disclosed range, his potential paper gain could be in the region of $350,000. In the week after ICE issued its contract notice, Axon’s stock surged by more than 34%.

ICE and its parent agency, the Department of Homeland Security (DHS), have not responded to requests for comment. Inquiries were made regarding the contract award status, the rationale behind the significant expansion of Taser procurement, the number of interested vendors, the potential for non-Axon suppliers to meet the requirements, and whether DHS secretary-level approval is necessary for the deal.

A source with knowledge of the procurement process, who requested anonymity due to concerns about potential repercussions, indicated that the Taser contract award may be facing delays due to its significant cost and recent leadership changes within DHS. The source noted that the ICE notice was issued approximately one week before the then-Homeland Security Secretary Kristi Noem was dismissed and prior to her final approval of the contract. Under Noem’s tenure, DHS policy mandated personal approval from the secretary’s office for expenditures exceeding $100,000. Homeland Security Secretary Markwayne Mullin rescinded this policy in April.

The timeline for the contract award remains uncertain, but it is anticipated that DHS will proceed with the procurement, according to the source familiar with the process.

For Axon, the potential financial benefits extend beyond Taser sales. The company, valued at approximately $35 billion, sees its primary growth driver in the policing infrastructure that complements its weapon systems. This includes cloud storage, evidence management systems, body cameras, real-time operational tools, and artificial intelligence products. Experts in law enforcement technology suggest that initial device orders can evolve into long-term technology partnerships.

“If Trump’s administration expands ICE’s capabilities, Axon is positioned to supply the technological backbone for these enhanced enforcement operations,” stated Matthew Guariglia, a senior policy analyst at the Electronic Frontier Foundation specializing in policing surveillance. “This could involve supplying cameras, cloud storage, software, and AI tools integral to a more robust federal enforcement apparatus.”

Axon currently holds a $370 million contract with DHS for body cameras and software, awarded in 2023. Of this amount, approximately $67.5 million has been obligated to date, according to HigherGov, a platform that tracks federal contracts.

The potential ICE Taser deal arrives as Axon is already experiencing unprecedented demand. The company reported its two highest-revenue quarters on record: $796.7 million in the fourth quarter of 2025, a 39% increase year-over-year, and $807.3 million in the first quarter of 2026, a 34% increase, driven by Taser sales and its rapidly growing AI products.

Axon executives highlighted DHS contracts as a “major opportunity” for the company during an investor call in February.

To capitalize on this growth, Axon has been expanding its federal team. On a May 6 earnings call, Axon President Joshua Isner announced the rebuilding of a significant portion of their federal team, including the hiring of Claudia Davidson, who previously spent over seven years at Palantir, assisting in the expansion of its federal agency business.

“We are observing renewed interest in body cameras and Tasers within federal law enforcement,” Isner informed investors, adding that Axon’s federal business is “trending very positively” and could see a “banner year” with favorable developments.

However, civil liberties advocates express concerns about ICE’s increasing integration into Axon’s surveillance ecosystem. Axon’s software capabilities integrate live feeds from various sources, including body cameras, drones, and fixed surveillance cameras. If ICE expands its operations and collaborates more closely with state and local law enforcement, such a system could provide federal agents with real-time situational awareness.

“If they can connect to Ring cameras, livestreams, body cameras, and other local feeds, it transcends officer safety or accountability,” Guariglia cautioned. “It becomes a platform that offers federal law enforcement a real-time overview of locations, ground activities, and the ability to coordinate responses with local precision.”

Axon announced a partnership with Ring in 2025, allowing Ring users to voluntarily share footage with law enforcement through Axon’s evidence platform. Additionally, Axon’s Fusus platform consolidates feeds from community cameras, body cameras, drones, and other sources onto a unified, real-time map.

Fleischaker noted that the proposed expansion of Taser usage through the DHS contract aligns with the Trump administration’s broader immigration enforcement agenda. “This underscores our understanding that the Trump administration intends to intensify immigration enforcement to unprecedented levels,” Fleischaker stated. “This necessitates significant resources for enforcement, and the procurement of Tasers is integral to these efforts.”

Axon’s strategic growth initiatives have also involved increased lobbying efforts in Washington D.C. Last year, Axon allocated nearly $2.5 million to lobbying, its highest annual expenditure, according to OpenSecrets, a non-profit tracking political spending. These efforts targeted legislation and regulatory frameworks concerning body cameras, counter-drone technology, digital evidence management, and other law enforcement products the company is promoting to federal agencies.

This lobbying push appears to be yielding results. Congress has proposed a $20 million allocation in DHS appropriations mandating that immigration enforcement agents be equipped with body cameras, a measure attributed in part to Axon’s substantial lobbying efforts, according to policing experts. Democrats have also supported this initiative, with Senators Ruben Gallego and Mark Kelly introducing legislation requiring all DHS officers to wear body cameras. While this bill currently lacks Republican support and is unlikely to advance in the Republican-controlled Senate, it highlights bipartisan interest in body camera adoption.

Donors associated with Axon contributed over $20,000 to Gallego during the 2024 Senate election cycle, according to OpenSecrets. Gallego and Kelly, who have publicly advocated for body camera and use-of-force regulations for ICE, have not responded to requests for comment regarding Axon’s potential benefit from these mandates.

On Capitol Hill, Democrats have championed body cameras as a crucial accountability measure and a valuable bargaining tool in negotiations with Republicans. For Axon, these cameras also serve as a gateway product, enabling federal officers to integrate with the company’s cloud storage, evidence management software, and AI tools, according to policing experts.

“Body cameras can establish enduring technology relationships with law enforcement agencies because the generated footage requires storage, management, analysis, and integration into broader evidence systems,” Guariglia explained.

Axon’s political spending has also faced scrutiny from its shareholders. The Nathan Cummings Foundation filed a lawsuit against Axon in January, seeking to prevent the company from excluding a shareholder proposal that called for greater transparency in its political spending. Richard Kirby, a former SEC attorney who represented the foundation, commented that Axon has “spent enormous amounts of money in politics to curry favor and support contracts and laws that benefit the company” since the Trump administration took office, underscoring the need for investor transparency.